Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "Aurobindo"

153 News Found

Aurobindo Pharma’s subsidiary opens logistics centre in France
Supply Chain | September 30, 2021

Aurobindo Pharma’s subsidiary opens logistics centre in France

The site's strategic location in the logistics hubs of the Auvergne Rhone-Alpes region is an advantage, along with the benefit of geographical proximity to Arrow's headquarters in Lyon


Aurobindo subsidiary submits MAA for oncology biosimilar
Biotech | September 23, 2021

Aurobindo subsidiary submits MAA for oncology biosimilar

CuraTeQ Biologics is on track for filing a second oncology biosimilar


Aurobindo subsidiary, Eugia gets US FDA approval for Cyclophosphamide injection
Drug Approval | August 27, 2021

Aurobindo subsidiary, Eugia gets US FDA approval for Cyclophosphamide injection

The product will be available in 500 mg/2.5 mL and 1 g/5 mL vials


Aurobindo Pharma calls off its acquisition of Cronus Pharma
News | August 21, 2021

Aurobindo Pharma calls off its acquisition of Cronus Pharma

The acquisition was expected to be completed in eight weeks, and it would have provided it with a foothold in the US $ 48 billion global animal health market


Aurobindo Pharma buys Cronus Pharma Specialities for Rs 420 crores
News | August 13, 2021

Aurobindo Pharma buys Cronus Pharma Specialities for Rs 420 crores

The acquisition will provide it with a foothold in the US $ 48 billion global animal health market


Progress on new ventures key for Aurobindo Pharma: ICICI Securities
News | June 02, 2021

Progress on new ventures key for Aurobindo Pharma: ICICI Securities

Aurobindo has one of the most enduring generics ecosystems among peers


Aurobindo Pharma Q4FY21 consolidated net profit at Rs. 801.58 Cr
News | May 31, 2021

Aurobindo Pharma Q4FY21 consolidated net profit at Rs. 801.58 Cr

The company reported total income of Rs.24774.63 crores during the 12 months period ended March 31, 2021


Aurobindo Pharma to acquire 26% ownerships solar power companies
News | February 24, 2021

Aurobindo Pharma to acquire 26% ownerships solar power companies

The company will be holding 26% of the share capital in each of the solar power generating companies.


Aurobindo Pharma gets approval for 3 products under PLI Scheme: ICICI Securities
News | January 26, 2021

Aurobindo Pharma gets approval for 3 products under PLI Scheme: ICICI Securities

Post approval under the PLI scheme, Aurobindo will become a very large player in anti-biotic space.


Granules India elevates Ananda Babu Doppalapudi as GM and Head Quality for Vizag API Unit
People | June 16, 2026

Granules India elevates Ananda Babu Doppalapudi as GM and Head Quality for Vizag API Unit

Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility